We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+8.34%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.86B
AUM Growth
+$107M
Cap. Flow
+$60.9M
Cap. Flow %
2.13%
Top 10 Hldgs %
78.63%
Holding
49
New
5
Increased
3
Reduced
–
Closed
5

Top Buys

Rank Stock Value
1
SYBX
Synlogic
SYBX
+$46.3M
2
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$35M
3
IMMU
Immunomedics Inc
IMMU
+$27.6M
4
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$15.4M
5
RGLS
Regulus Therapeutics
RGLS
+$11.5M

Top Sells

Rank Stock Value
1
GRPN icon
Groupon
GRPN
+$38.5M
2
NVRO
NEVRO CORP.
NVRO
+$26.8M
3
SNAP icon
Snap
SNAP
+$14.5M
4
HIVE
Aerohive Networks
HIVE
+$5.61M
5
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 88.61%
2 Consumer Discretionary 1.81%
3 Technology 0.87%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NITE
26
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$13.7M 0.48%
+714,285
New +$15.4M
ELGX
27
DELISTED
Endologix Inc
ELGX
$11.1M 0.39%
249,020
– –
TRVN
28
DELISTED
Trevena, Inc.
TRVN
$9.72M 0.34%
6,099
– –
AFMD
29
DELISTED
Affimed
AFMD
$8.75M 0.31%
388,889
– –
TCON
30
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$8.69M 0.3%
13,796
– –
RIGL icon
31
Rigel Pharmaceuticals
RIGL
$723M
$8.24M 0.29%
324,315
– –
KA
32
DELISTED
Kineta, Inc. Common Stock
KA
$7.47M 0.26%
25,406
– –
DZSI
33
DELISTED
DZS Inc. Common Stock
DZSI
$6.53M 0.23%
956,255
– –
CSBR icon
34
Champions Oncology
CSBR
$75.9M
$5.73M 0.2%
1,562,500
– –
TRIL
35
DELISTED
Trillium Therapeutics Inc.
TRIL
$5.41M 0.19%
1,050,000
– –
ARQL
36
DELISTED
Arqule Inc
ARQL
$2.8M 0.1%
2,520,316
– –
AKTX
37
Akari Therapeutics
AKTX
$14.4M
$2.78M 0.1%
565
– –
VIRX
38
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.52M 0.09%
37,094
– –
PXLW icon
39
Pixelworks
PXLW
$37.2M
$1.69M 0.06%
+29,963
New +$1.69M
ORKA
40
Oruka Therapeutics
ORKA
$5.31B
$1.68M 0.06%
6,760
– –
OREX
41
DELISTED
Orexigen Therapeutics, Inc.
OREX
$786K 0.03%
370,900
– –
ROKA
42
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$652K 0.02%
893,471
– –
AVTX icon
43
Avalo Therapeutics
AVTX
$1.01B
$506K 0.02%
207
– –
GYRE icon
44
Gyre Therapeutics
GYRE
$629M
$220K 0.01%
5,799
– –
GRPN icon
45
Groupon
GRPN
$1.03B
– –
-501,894
Closed -$38.5M
SNAP icon
46
Snap
SNAP
$7.96B
– –
-813,802
Closed -$14.5M
NVRO
47
DELISTED
NEVRO CORP.
NVRO
– –
-359,678
Closed -$26.8M
PRTK
48
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-66,245
Closed -$1.6M
HIVE
49
DELISTED
Aerohive Networks
HIVE
– –
-1,121,080
Closed -$5.61M
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q3 2017 Portfolio in Review

As of Q3 2017, NEA Management Company held 49 positions worth $2.86B, up 3.9% from $2.75B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

NEA Management Company's Q3 2017 filing shows 5 new, 3 increased and 5 closed positions. Its largest new stake was Clementia Pharmaceuticals Inc.: 2,141,697 shares worth $36.2M. The largest sale was Groupon, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 85% a quarter earlier, followed by Consumer Discretionary and Technology.

  • NEA Management Company's largest Q3 2017 buy was Clementia Pharmaceuticals Inc.: 2,141,697 shares worth $36.2M.
  • NEA Management Company added most to Synlogic in Q3 2017, an estimated $46.3M increase.
  • NEA Management Company fully exited Groupon in Q3 2017, selling an estimated $38.5M.
  • NEA Management Company's ten largest holdings make up 79% of its $2.86B portfolio in Q3 2017.
  • NEA Management Company opened 5 new positions and closed 5 in Q3 2017.
  • NEA Management Company's portfolio value rose 3.9% quarter-over-quarter to $2.86B.

Based on NEA Management Company's 13F filing for Q3 2017, filed 3 Nov 2017.